Dr. Brar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2825 Livernois Rd
Troy, MI 48083Phone+1 313-916-2600
Education & Training
Boston University Medical CenterFellowship, Infectious Disease, 1994 - 1997
UMass Chan Medical SchoolResidency, Internal Medicine, 1991 - 1993
SUNY Downstate Health Sciences UniversityInternship, Internal Medicine, 1990 - 1991
Christian Medical College LudhianaClass of 1987
Certifications & Licensure
MI State Medical License 1998 - 2026
MA State Medical License 1992 - 2003- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Post-Exposure Prophylaxis in Health Care Workers Start of enrollment: 2011 Feb 01
Publications & Presentations
PubMed
- Prescribing Practices of Recommended Treatment for Trichomonas vaginalis and Chlamydia trachomatis After 2021 Sexually Transmitted Infection Treatment Guideline Update.Christen J Arena, Rachel M Kenney, Erin Eriksson, Indira Brar, Michael P Veve
Sexually Transmitted Diseases. 2024-11-01 - 2 citationsVaccine coverage and factors associated with vaccine adherence in persons with HIV at an urban infectious disease clinic.Navina K Birk, Lea Monday, Tarandeep Singh, Medha Cherabuddi, Marwa Hojeij
Human Vaccines & Immunotherapeutics. 2023-12-31 - 2 citationsOutcomes associated with SARS-CoV-2 reinfection in individuals with natural and hybrid immunity.Geehan Suleyman, Raef Fadel, Kunj Patel, Al Muthanna Shadid, Haim Bernardo Cotlear Stuart
Journal of Infection and Public Health. 2023-08-01
Press Mentions
Global Health Research Collaborative Panel Discussions Open to All Beginning July 22July 11th, 2022- OTC Meds, Supplements, and Other Drugs May Interact with HIV AntiretroviralsMay 23rd, 2022
- Despite FDA Delay, Convalescent Plasma Trials Continue in MichiganAugust 20th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
